Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.36 |
| ▸ | DPP4 | P27487 | 2/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.35 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872971 | 1.00 | MEN1 (0.37) | MEN1CYP2D6KMT2AALDH1A1CHRM2 | |
| SCHEMBL27865953 | 0.96 | MEN1 (0.41) | MEN1CYP2D6KMT2AALDH1A1CHRM2 | |
| SCHEMBL11122133 | 0.85 | CHRM2 (0.43) | MEN1CYP2D6KMT2AALDH1A1CHRM2 | |
| SCHEMBL24879344 | 0.84 | MEN1 (0.41) | MEN1CYP2D6KMT2AALDH1A1CHRM2 | |
| SCHEMBL12172321 | 0.84 | CHRM2 (0.36) | MEN1CYP2D6KMT2AALDH1A1CHRM2 | |
| Hydrochloric Acid SCHEMBL28769363 | 0.83 | MEN1 (0.42) | MEN1CYP2D6KMT2AALDH1A1CHRM2 | |
| SCHEMBL25500893 | 0.83 | CHRM2 (0.42) | MEN1CYP2D6KMT2AALDH1A1CHRM2 | |
| SCHEMBL6060648 | 0.82 | CHRM2 (0.35) | MEN1CYP2D6KMT2AALDH1A1CHRM2 | |
| SCHEMBL26330098 | 0.82 | CYP19A1 (0.39) | MEN1CYP2D6KMT2AALDH1A1CHRM2 | |
| SCHEMBL2779120 | 0.82 | ALDH1A1 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1055 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441953-B2 | Isomer mixtures of unsaturated macrocyclic musk compounds | SYMRISE AG (DE) | 2025-10-14 | — | — | US | claimed |
| CN-111051483-B | Esters and ethers of 2, 4-tetramethyl cyclobutane-1, 3-diol as fragrance chemicals | 巴斯夫欧洲公司 | 2025-01-24 | — | — | CN | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| CN-109152711-B | Method for producing perfume capsules with improved surfactant stability | 西姆莱斯股份公司 | 2021-10-22 | — | — | CN | claimed |
| CN-113056547-A | Jasmine alcohol | 西姆莱斯有限公司 | 2021-06-29 | — | — | CN | claimed |
| US-10920170-B2 | Fragrance mixtures containing tricyclo[5.2.1.0]-decane-8-ethyl ether | SYMRISE AG (DE) | 2021-02-16 | — | — | US | claimed |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SYMRISE AG (DE) | 2020-12-29 | — | — | US | claimed |
| EP-3423028-B1 | METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS | SYMRISE AG (DE) | 2020-04-08 | — | — | EP | claimed |
| US-20200063063-A1 | FRAGRANCE MIXTURES CONTAINING TRICYCLO[5.2.1.0]-DECANE-8-ETHYL ETHER | SYMRISE AG (DE) | 2020-02-27 | — | — | US | claimed |
| US-8999913-B2 | Fragrance mixtures containing cyclopent-2-enyl ethyl acetate | SYMRISE AG (DE) | 2015-04-07 | — | — | US | claimed |
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| US-8609600-B2 | Encapsulation of bulky fragrance molecules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-17 | — | — | US | claimed |
| US-20130303432-A1 | Use Of Specific Compounds For Modifying Odors | SYMRISE AG (DE) | 2013-11-14 | — | — | US | claimed |
| US-20130172429-A1 | FRAGRANCE MIXTURES CONTAINING CYCLOPENT-2-ENYL ETHYL ACETATE | SYMRISE AG (DE) | 2013-07-04 | — | — | US | claimed |
| CN-103160375-A | Perfume mixtures containing cyclopent-2-enyl-ethyl acetate | SYMRISE AG | 2013-06-19 | — | — | CN | claimed |
| US-20110104089-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND NEOPENTYL GLYCOL DIISONONANOATE | SYMRISE AG (DE) | 2011-05-05 | — | — | US | claimed |
| EP-2211829-B1 | IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS | HENKEL AG & CO KGAA (DE) | 2011-04-27 | — | — | EP | claimed |
| US-20110091404-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE | SYMRISE AG (DE) | 2011-04-21 | — | — | US | claimed |
| US-20100210496-A1 | Fragrance Effect of Perfume Esters | BESSLER CORNELIUS | 2010-08-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10920170-B2 | Fragrance mixtures containing tricyclo[5.2.1.0]-decane-8-ethyl ether | CCT8, F8, TRPM8 | MEN1 3160/4885CYP2D6 944/4885KMT2A 1841/4885 |
| US-20200063063-A1 | FRAGRANCE MIXTURES CONTAINING TRICYCLO[5.2.1.0]-DECANE-8-ETHYL ETHER | CCT8, F8, TRPM8 | MEN1 3160/4885CYP2D6 944/4885KMT2A 1841/4885 |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SMOX, LIPA, SGMS2 | MEN1 1928/4885CYP2D6 1005/4885KMT2A 1413/4885 |
| US-20110091404-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE | CUTA, FHIT, FAM83A | MEN1 3946/4885CYP2D6 3351/4885KMT2A 3339/4885 |
| US-20110104089-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND NEOPENTYL GLYCOL DIISONONANOATE | CUTA, KIT, DEGS1 | MEN1 2461/4885CYP2D6 2380/4885KMT2A 2150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.